Bank of America Corp DE Increases Position in Seer, Inc. (NASDAQ:SEER)

Bank of America Corp DE increased its stake in Seer, Inc. (NASDAQ:SEER) by 18.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 151,337 shares of the company’s stock after purchasing an additional 23,411 shares during the quarter. Bank of America Corp DE’s holdings in Seer were worth $350,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in SEER. Y Intercept Hong Kong Ltd purchased a new stake in shares of Seer during the fourth quarter worth about $36,000. Corient Private Wealth LLC boosted its position in shares of Seer by 66.0% in the fourth quarter. Corient Private Wealth LLC now owns 33,200 shares of the company’s stock worth $77,000 after acquiring an additional 13,200 shares during the last quarter. Schonfeld Strategic Advisors LLC acquired a new position in Seer during the fourth quarter valued at approximately $103,000. Fuller & Thaler Asset Management Inc. acquired a new position in Seer during the fourth quarter valued at approximately $179,000. Finally, Dimensional Fund Advisors LP lifted its position in Seer by 4.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 127,711 shares of the company’s stock valued at $295,000 after buying an additional 5,000 shares in the last quarter. 75.20% of the stock is currently owned by hedge funds and other institutional investors.

Seer Trading Down 2.7%

NASDAQ SEER opened at $2.13 on Friday. The company’s fifty day simple moving average is $2.03 and its 200-day simple moving average is $2.15. Seer, Inc. has a 52 week low of $1.56 and a 52 week high of $2.63. The stock has a market cap of $125.39 million, a P/E ratio of -1.64 and a beta of 1.54.

Seer (NASDAQ:SEER) last released its earnings results on Tuesday, May 13th. The company reported ($0.34) earnings per share for the quarter, beating the consensus estimate of ($0.37) by $0.03. Seer had a negative net margin of 565.83% and a negative return on equity of 21.96%. The firm had revenue of $4.21 million during the quarter, compared to analyst estimates of $3.25 million. On average, research analysts expect that Seer, Inc. will post -1.42 EPS for the current fiscal year.

About Seer

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.